Home › Funds › Vestal Point Capital, LP › VKTX

Vestal Point Capital, LP position in VKTX

VIKING THERAPEUTICS INC · Health Care

Vestal Point Capital, LP reported holding 680,000 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$26.5M, representing 0.62% of its reported portfolio and ranking #39 among its reported holdings. Vestal Point Capital, LP has disclosed VKTX holdings in 3 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)680.00K sh
Reported value held$26.53M
Portfolio Weight0.62%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's VKTX position evolved

Vestal Point Capital, LP first disclosed a stake in VKTX in Q1 2024 at 75,000 shares (US$6.2M). The position peaked in Q1 2026 at 914,147 shares, worth US$29.7M. Across 3 filings, Vestal Point Capital, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 680,000 shares valued at US$26.5M — a reduction of -234,147 shares quarter over quarter.. Notable position changes include a 26% trim in Q2 2026 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 75.00K $6.15M New
Q1 2026 914.15K $29.75M New
Q2 2026 680.00K $26.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VKTX and 13F data

VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 34 other funds we track also report a position in VKTX — the largest reported positions include Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M), TANG CAPITAL MANAGEMENT LLC (US$19.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VKTX

All VKTX fund holders →

FAQ

How long has Vestal Point Capital, LP held VKTX?

Vestal Point Capital, LP has disclosed VKTX holdings in 3 of the last 10 reported quarters, going back to Q1 2024.

What is Vestal Point Capital, LP's current position in VKTX?

As of Q2 2026, Vestal Point Capital, LP holds 680.00K shares of VKTX (VIKING THERAPEUTICS INC), valued at $26.53M, representing 0.62% of its reported portfolio and ranking #39.

Has Vestal Point Capital, LP been buying or selling VKTX?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP reduced its position in VKTX. The position peaked in Q1 2026 at 914.15K shares.

Which other funds hold VKTX?

Other major institutional holders of VKTX include Eversept Partners, LP, ADAR1 Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.